Table 1. Baseline Characteristics of People With a New Diagnosis of HIV Who Were Eligible for the MenACWY Vaccine.
| Characteristic | No. (%) (N = 1208) |
|---|---|
| Age, mean (SD), y | 38.8 (12.5) |
| Age group, y | |
| 2-18 | 13 (1.1) |
| 19-55 | 1064 (88.1) |
| ≥56 | 131 (10.8) |
| Sex | |
| Male | 1024 (84.8) |
| Female | 184 (15.2) |
| Race and ethnicitya | |
| Hispanic | 204 (16.9) |
| Non-Hispanic | |
| Asian | 35 (2.9) |
| Black or African American | 273 (22.6) |
| White or Caucasian | 442 (36.6) |
| Other | 10 (0.8) |
| Multiple or unknown | 214 (17.7) |
| Geographic region of residence | |
| South | 688 (57.0) |
| Midwest | 209 (17.3) |
| West | 175 (14.5) |
| Northeast | 135 (11.2) |
| Other | 1 (0.1) |
| Health plan type | |
| Point of service | 909 (75.2) |
| Exclusive provider organization | 188 (15.6) |
| Health maintenance organization | 89 (7.4) |
| Other or unknown | 22 (1.8) |
| Year of index date | |
| 2016 | 609 (50.4) |
| 2017 | 524 (43.4) |
| 2018 | 75 (6.2) |
Abbreviation: MenACWY, meningococcal serogroups A, C, W, Y.
a
Estimated by an algorithm based on Census data zip codes (zip +4 digits) and first and last names. Other includes Native American, Alaska Native, and Pacific Islander.